Ivermectin didn’t curb COVID-19 hospitalizations in largest study to date

In a trial of nearly 1,400 COVID-19 patients, those who received the antiparasitic drug ivermectin didn’t fare better than those who received a placebo, The Wall Street Journal reported March 18.